» Articles » PMID: 34538094

Diffusion and Quantification of Diffusion of Prostate Cancer

Overview
Journal Br J Radiol
Specialty Radiology
Date 2021 Sep 20
PMID 34538094
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

For assessing a cancer treatment, and for detecting and characterizing cancer, Diffusion-weighted imaging (DWI) is commonly used. The key in DWI's use extracranially has been due to the emergence of of high-gradient amplitude and multichannel coils, parallelimaging, and echo-planar imaging. The benefit has been fewer motion artefacts and high-quality prostate images.Recently, new techniques have been developed to improve the signal-to-noise ratio of DWI with fewer artefacts, allowing an increase in spatial resolution. For apparent diffusion coefficient quantification, non-Gaussian diffusion models have been proposed as additional tools for prostate cancer detection and evaluation of its aggressiveness. More recently, radiomics and machine learning for prostate magnetic resonance imaging have emerged as novel techniques for the non-invasive characterisation of prostate cancer. This review presents recent developments in prostate DWI and discusses its potential use in clinical practice.

Citing Articles

Squared diffusion-weighted imaging for improving the detection of clinically significant prostate cancer.

Valentin B, Schimmoller L, Boschheidgen M, Ullrich T, Thiel T, Ljimani A Sci Rep. 2025; 15(1):3451.

PMID: 39870725 PMC: 11772849. DOI: 10.1038/s41598-025-86068-x.


Case report: Prostatic malakoplakia: a rare disease that has a profile mimicking prostate cancer.

Ren Y, Chen W, Zhang M, Zhang X, Zhou J, Li Y Front Oncol. 2024; 14:1348797.

PMID: 38665958 PMC: 11043519. DOI: 10.3389/fonc.2024.1348797.


Diffusion kurtosis imaging and standard diffusion imaging in the magnetic resonance imaging assessment of prostate cancer.

Palumbo P, Martinese A, Antenucci M, Granata V, Fusco R, De Muzio F Gland Surg. 2024; 12(12):1806-1822.

PMID: 38229839 PMC: 10788566. DOI: 10.21037/gs-23-53.


Acquisition Parameters Influence Diffusion Metrics Effectiveness in Probing Prostate Tumor and Age-Related Microstructure.

Caporale A, Nezzo M, Di Trani M, Maiuro A, Miano R, Bove P J Pers Med. 2023; 13(5).

PMID: 37241031 PMC: 10222109. DOI: 10.3390/jpm13050860.


Truly reproducible uniform estimation of the ADC with multi-b diffusion data- Application in prostate diffusion imaging.

Kuczera S, Langkilde F, Maier S Magn Reson Med. 2022; 89(4):1586-1600.

PMID: 36426737 PMC: 10100221. DOI: 10.1002/mrm.29533.


References
1.
Katahira K, Takahara T, Kwee T, Oda S, Suzuki Y, Morishita S . Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol. 2010; 21(1):188-96. DOI: 10.1007/s00330-010-1883-7. View

2.
Saritas E, Cunningham C, Lee J, Han E, Nishimura D . DWI of the spinal cord with reduced FOV single-shot EPI. Magn Reson Med. 2008; 60(2):468-73. DOI: 10.1002/mrm.21640. View

3.
Liu X, Zhou L, Peng W, Wang H, Zhang Y . Comparison of stretched-Exponential and monoexponential model diffusion-Weighted imaging in prostate cancer and normal tissues. J Magn Reson Imaging. 2015; 42(4):1078-85. DOI: 10.1002/jmri.24872. View

4.
Stoyanova R, Takhar M, Tschudi Y, Ford J, Solorzano G, Erho N . Prostate cancer radiomics and the promise of radiogenomics. Transl Cancer Res. 2017; 5(4):432-447. PMC: 5703221. DOI: 10.21037/tcr.2016.06.20. View

5.
Tamada T, Kanomata N, Sone T, Jo Y, Miyaji Y, Higashi H . High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness. PLoS One. 2014; 9(5):e96619. PMC: 4011860. DOI: 10.1371/journal.pone.0096619. View